Imperial College London
Portrait Picture

DrJonathanKrell

Faculty of Medicine, Department of Surgery & Cancer

Clinical SL in Medical Oncology (Gynaecological Oncology)
 
 
 
//

Contact

 

j.krell

 
 
//

Location

 

Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Gourley:2018:10.1200/JCO.2018.36.15_suppl.TPS5612,
author = {Gourley, C and Dalton, HJ and Banerjee, SN and Buscema, J and Lockley, M and Krell, J and Monk, BJ},
doi = {10.1200/JCO.2018.36.15_suppl.TPS5612},
publisher = {AMER SOC CLINICAL ONCOLOGY},
title = {PRO-105, a phase II open-label study of NUC-1031 in patients with platinum-resistant ovarian cancer.},
url = {http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.TPS5612},
year = {2018}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Gourley,C
AU  - Dalton,HJ
AU  - Banerjee,SN
AU  - Buscema,J
AU  - Lockley,M
AU  - Krell,J
AU  - Monk,BJ
DO  - 10.1200/JCO.2018.36.15_suppl.TPS5612
PB  - AMER SOC CLINICAL ONCOLOGY
PY  - 2018///
SN  - 0732-183X
TI  - PRO-105, a phase II open-label study of NUC-1031 in patients with platinum-resistant ovarian cancer.
UR  - http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.TPS5612
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000442916007689&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER  -
Download